SMTL ID : 7xlp.1

MEK1 bound to DS03090629

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.10 Å

Oligo State

monomer

Ligands

1 x FZC: (1~{R},3~{S})-3-[[6-[2-chloranyl-4-(4-methylpyrimidin-2-yl)oxy-phenyl]-3-methyl-1~{H}-indazol-4-yl]oxy]cyclohexan-1-amine(Non-covalent)

FZC.1: 19 residues within 4Å: Chain A: L.39, G.40, A.41, V.47, A.60, K.62, L.80, L.83, I.106, M.108, E.109, H.110, M.111, G.114, S.159, N.160, L.162, D.173, F.174 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:V.47, A:A.60, A:K.62, A:K.62, A:L.83, A:I.106, A:L.162, A:F.174 Hydrogen bonds: A:E.109, A:M.111, A:D.173 Water bridges: A:S.159, A:D.173, A:D.173 Halogen bonds: A:A.60

1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.2: 4 residues within 4Å: Chain A: A.312, R.314, D.316, Q.319 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:Q.319 Salt bridges: A:D.316

3 x CA: CALCIUM ION(Non-covalent)

CA.3: 4 residues within 4Å: Chain A: D.30, D.31, D.101 Ligands: CA.4 2 PLIP interactions: 2 interactions with chain A Metal complexes: A:D.30, A:D.31 CA.4: 2 residues within 4Å: Chain A: D.30 Ligands: CA.3 3 PLIP interactions: 2 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:D.30, A:D.30, H2O.3 CA.5: 1 residues within 4Å: Chain A: D.173 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Takano, K. et al., Discovery of a Novel ATP-Competitive MEK Inhibitor DS03090629 that Overcomes Resistance Conferred by BRAF Overexpression in BRAF-Mutated Melanoma. Mol.Cancer Ther. (2023)

Release Date

2023-03-01

Peptides

Dual specificity mitogen-activated protein kinase kinase 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Dual specificity mitogen-activated protein kinase kinase 1

Related Entries With Identical Sequence